FDA Drug Recalls

Recalls / Active ingredient / Glimepiride

Glimepiride

8 FDA drug recalls involving the active ingredient “Glimepiride”.

DateClassProductFirm
2024-01-18Class IIIGlimepiride Tablets, USP 1mg, 500-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, SrikakulaDr. Reddy's Laboratories, Inc.
2024-01-18Class IIIGlimepiride Tablets, USP 1mg, 100-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, SrikakulaDr. Reddy's Laboratories, Inc.
2023-03-16Class IIGlimepiride Tablets, USP 4mg, packaged in a) 30-count bottles (NDC 51655-120-52), and b) 90-count bottles (NDCNorthwind Pharmaceuticals LLC
2023-03-16Class IIGlimepiride Tablets, USP 2mg, packaged in a) 30-count bottles (NDC 51655-383-52), and b)90-count bottles (NDC Northwind Pharmaceuticals LLC
2023-02-07Class IIGlimepiride Tablets USP, 2 mg, Rx Only, Packaged in: a) 100 Tablets NDC 16729-002-01 UPC 3 16729 00201 1; b) 5Accord Healthcare, Inc.
2023-02-07Class IIGlimepiride Tablets USP, 4 mg, Rx Only, Packaged in: a) 100-count bottle NDC 16729-003-01 UPC 3 16729 00301 8;Accord Healthcare, Inc.
2023-02-07Class IIGlimepiride Tablets USP, 1 mg, Rx Only, Packaged in: a) 100-count bottle NDC 16729-001-01 UPC 3 16729 00101 4Accord Healthcare, Inc.
2014-10-09Class IIGLIMEPIRIDE TABLETS, USP 2 mg, a)100 count bottle, (NDC 42571-101-01), b) 500 count Bottle (NDC 42571-101-05)Micro Labs Usa, Inc S